Mechanism of antihypertensive action of ketanserin in man.
作者信息
Ball S G, Zabludowski J R, Robertson J I
出版信息
Br Med J (Clin Res Ed). 1983 Oct 8;287(6398):1065. doi: 10.1136/bmj.287.6398.1065.
Abstract
摘要
相似文献
1
Mechanism of antihypertensive action of ketanserin in man.酮色林在人体中的降压作用机制。
Br Med J (Clin Res Ed). 1983 Oct 8;287(6398):1065. doi: 10.1136/bmj.287.6398.1065.
2
Mechanism of antihypertensive action of ketanserin in man.酮色林对人体的降压作用机制。
Br Med J (Clin Res Ed). 1983 Aug 6;287(6389):381-3. doi: 10.1136/bmj.287.6389.381-a.
3
Mechanism of antihypertensive action of ketanserin in man.酮色林对人体的降压作用机制。
Br Med J (Clin Res Ed). 1983 Oct 29;287(6401):1300-1. doi: 10.1136/bmj.287.6401.1300-b.
4
Antihypertensive mode of action of ketanserin.酮色林的降压作用机制。
J Cardiovasc Pharmacol. 1987;10 Suppl 3:S45-7.
5
Acute blood-pressure-lowering effect of ketanserin.酮色林的急性降压作用。
Lancet. 1981 May 23;1(8230):1161-2. doi: 10.1016/s0140-6736(81)92331-x.
6
Antihypertensive effects of ketanserin in the spontaneously hypertensive rat: mode of action.
J Cardiovasc Pharmacol. 1985;7 Suppl 7:S110-1. doi: 10.1097/00005344-198500077-00031.
7
Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.酮色林（R 41 468）对大鼠降压特性的表征
J Pharmacol Exp Ther. 1982 Jul;222(1):227-31.
8
Mechanism of the hypotensive effect of ketanserin.酮色林降压作用的机制。
J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):829-38. doi: 10.1097/00005344-198209000-00020.
9
Is ketanserin a D receptor antagonist?
Lancet. 1983 Mar 26;1(8326 Pt 1):703-4.
10
Antihypertensive properties of ketanserin (R 41 468).酮色林（R 41 468）的降压特性。
Fed Proc. 1983 Feb;42(2):182-5.
引用本文的文献
1
Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.5-羟色胺2型受体拮抗剂酮色林对原发性高血压患者血压、肾素-血管紧张素系统及交感-肾上腺功能的影响
Br J Clin Pharmacol. 1984 Mar;17(3):309-16. doi: 10.1111/j.1365-2125.1984.tb02346.x.
2
Response to tilting in hypertensive patients receiving ketanserin.接受酮色林治疗的高血压患者对倾斜试验的反应。
Eur J Clin Pharmacol. 1986;31(4):505-6. doi: 10.1007/BF00613533.
3
In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.选择性5-羟色胺2受体拮抗剂的体内和体外活性
Br J Pharmacol. 1986 Sep;89(1):129-35. doi: 10.1111/j.1476-5381.1986.tb11128.x.
4
Controlled trial of ketanserin in hypertension.酮色林治疗高血压的对照试验。
Br J Clin Pharmacol. 1985 Jul;20(1):37-40. doi: 10.1111/j.1365-2125.1985.tb02795.x.
5
Ketanserin in essential hypertension: a double-blind, placebo-controlled study.酮色林治疗原发性高血压：一项双盲、安慰剂对照研究。
Postgrad Med J. 1985 Jul;61(717):583-6. doi: 10.1136/pgmj.61.717.583.
6
Effect of intravenous ketanserin on plasma catecholamines and renin activity in normal volunteers.静脉注射酮色林对正常志愿者血浆儿茶酚胺和肾素活性的影响。
Eur J Clin Pharmacol. 1985;28(3):273-7. doi: 10.1007/BF00543323.
7
Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat.
Naunyn Schmiedebergs Arch Pharmacol. 1985 Jun;329(4):394-7. doi: 10.1007/BF00496374.
8
Comparative haemodynamic effects of ketanserin and ritanserin in the proximal and distal upper limb circulations of hypertensive patients.酮色林和利坦色林对高血压患者上肢近端和远端循环的血流动力学比较效应
Eur J Clin Pharmacol. 1989;37(3):215-20. doi: 10.1007/BF00679772.
9
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.酮色林。对其药效学和药代动力学特性以及在高血压和外周血管疾病中的治疗潜力的综述。
Drugs. 1990 Dec;40(6):903-49. doi: 10.2165/00003495-199040060-00010.
本文引用的文献
1
Is ketanserin a D receptor antagonist?
Lancet. 1983 Mar 26;1(8326 Pt 1):703-4.
Zotero 插件